Detailed Information

Cited 1 time in webofscience Cited 1 time in scopus
Metadata Downloads

Association Between Curative Treatment after Transarterial Radioembolization and Better Survival Outcomes in Patients with Hepatocellular Carcinoma

Authors
Kim, YunaLee, Han AhLee, Jae SeungJeon, Mi YoungKim, Beom KyungPark, Jun YongKim, Do YoungAhn, Sang HoonUm, Soon HoSeo, Yeon SeokKim, Seung Up
Issue Date
16-Mar-2021
Publisher
TAYLOR & FRANCIS INC
Keywords
TARE; radioembolization; Yttrium-90; hepatocellular carcinoma; curative treatment
Citation
CANCER INVESTIGATION, v.39, no.3, pp.274 - 283
Indexed
SCIE
SCOPUS
Journal Title
CANCER INVESTIGATION
Volume
39
Number
3
Start Page
274
End Page
283
URI
https://scholarworks.korea.ac.kr/kumedicine/handle/2020.sw.kumedicine/51671
DOI
10.1080/07357907.2020.1870126
ISSN
0735-7907
Abstract
Transarterial radioembolization (TARE) is one of the therapeutic options for hepatocellular carcinoma (HCC). This study aimed to investigate the predictors and prognostic values of achieving curative treatments after TARE. Overall, 143 patients with intrahepatic HCC treated with TARE between 2011 and 2017 were recruited from two Korean tertiary institutes. Twenty-seven patients received curative treatments after TARE. Younger age than 65 years and AFP of <= 200 ng/mL independently predicted the increased probability of achieving curative treatment after TARE, and the curative treatment after TARE provided a survival benefit in patients with intrahepatic HCC.
Files in This Item
There are no files associated with this item.
Appears in
Collections
2. Clinical Science > Department of Gastroenterology and Hepatology > 1. Journal Articles

qrcode

Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.

Related Researcher

Researcher Seo, Yeon Seok photo

Seo, Yeon Seok
Anam Hospital (Department of Gastroenterology and Hepatology, Anam Hospital)
Read more

Altmetrics

Total Views & Downloads

BROWSE